457 related articles for article (PubMed ID: 35118842)
1. Current Immunotherapeutic Approaches for Malignant Gliomas.
Han MH; Kim CH
Brain Tumor Res Treat; 2022 Jan; 10(1):1-11. PubMed ID: 35118842
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy: a promising approach for glioma treatment.
Yasinjan F; Xing Y; Geng H; Guo R; Yang L; Liu Z; Wang H
Front Immunol; 2023; 14():1255611. PubMed ID: 37744349
[TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy in brain tumors].
De Carli E; Delion M; Rousseau A
Ann Pathol; 2017 Feb; 37(1):117-126. PubMed ID: 28111040
[TBL] [Abstract][Full Text] [Related]
4. Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy.
Dunn GP; Cloughesy TF; Maus MV; Prins RM; Reardon DA; Sonabend AM
Neuro Oncol; 2020 Oct; 22(10):1425-1438. PubMed ID: 32615600
[TBL] [Abstract][Full Text] [Related]
5. The current state of immunotherapy for gliomas: an eye toward the future.
Fecci PE; Sampson JH
J Neurosurg; 2019 Sep; 131(3):657-666. PubMed ID: 31473668
[TBL] [Abstract][Full Text] [Related]
6. The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.
Maxwell R; Luksik AS; Garzon-Muvdi T; Lim M
Curr Neurol Neurosci Rep; 2017 Jun; 17(6):50. PubMed ID: 28488122
[TBL] [Abstract][Full Text] [Related]
7. Cellular immunotherapy for malignant gliomas.
Lin Y; Okada H
Expert Opin Biol Ther; 2016 Oct; 16(10):1265-75. PubMed ID: 27434205
[TBL] [Abstract][Full Text] [Related]
8. Introduction to immunotherapy for brain tumor patients: challenges and future perspectives.
Montoya ML; Kasahara N; Okada H
Neurooncol Pract; 2020 Oct; 7(5):465-476. PubMed ID: 33014387
[TBL] [Abstract][Full Text] [Related]
9. Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top".
Simonelli M; Persico P; Perrino M; Zucali PA; Navarria P; Pessina F; Scorsetti M; Bello L; Santoro A
Cancer Treat Rev; 2018 Sep; 69():121-131. PubMed ID: 29966936
[TBL] [Abstract][Full Text] [Related]
10. Challenges in clinical design of immunotherapy trials for malignant glioma.
Rolle CE; Sengupta S; Lesniak MS
Neurosurg Clin N Am; 2010 Jan; 21(1):201-14. PubMed ID: 19944979
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Translational Advances in Glioma Immunotherapy.
Bunse L; Bunse T; Krämer C; Chih YC; Platten M
Neurotherapeutics; 2022 Oct; 19(6):1799-1817. PubMed ID: 36303101
[TBL] [Abstract][Full Text] [Related]
12. Current Immunotherapies for Glioblastoma Multiforme.
Huang B; Li X; Li Y; Zhang J; Zong Z; Zhang H
Front Immunol; 2020; 11():603911. PubMed ID: 33767690
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for Malignant Glioma: Current Status and Future Directions.
Wang H; Xu T; Huang Q; Jin W; Chen J
Trends Pharmacol Sci; 2020 Feb; 41(2):123-138. PubMed ID: 31973881
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy approaches in the treatment of malignant brain tumors.
Dunn-Pirio AM; Vlahovic G
Cancer; 2017 Mar; 123(5):734-750. PubMed ID: 27875627
[TBL] [Abstract][Full Text] [Related]
15. Emerging immunotherapies for glioblastoma.
Desai R; Suryadevara CM; Batich KA; Farber SH; Sanchez-Perez L; Sampson JH
Expert Opin Emerg Drugs; 2016 Jun; 21(2):133-45. PubMed ID: 27223671
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal immunotherapy with human monoclonal antibody(CLN-IgG) in glioma patients].
Kubo O; Takakura K
Nihon Rinsho; 2002 Mar; 60(3):497-503. PubMed ID: 11904965
[TBL] [Abstract][Full Text] [Related]
17. The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain.
Weller M; Fontana A
Brain Res Brain Res Rev; 1995 Sep; 21(2):128-51. PubMed ID: 8866671
[TBL] [Abstract][Full Text] [Related]
18. Principles of immunotherapy.
Liebelt BD; Finocchiaro G; Heimberger AB
Handb Clin Neurol; 2016; 134():163-81. PubMed ID: 26948354
[TBL] [Abstract][Full Text] [Related]
19. Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy.
Mishchenko TA; Turubanova VD; Gorshkova EN; Krysko O; Vedunova MV; Krysko DV
Front Immunol; 2023; 14():1299064. PubMed ID: 38274827
[TBL] [Abstract][Full Text] [Related]
20. [Immunotherapy against gliomas].
Sahm K; Weiss T
Nervenarzt; 2024 Feb; 95(2):111-116. PubMed ID: 38169045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
